Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 647389, 11 pages
http://dx.doi.org/10.1155/2015/647389
Research Article

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort

1Institute of Biomedical Engineering, College of Automation, Harbin Engineering University, 145 Nantong Street, Harbin 150001, China
2Center for Bioinformatics, College of Automation, Harbin Engineering University, 145 Nantong Street, Harbin 150001, China
3College of Information Engineering, Northeast Dianli University, 169 Changchun Street, Jilin 132012, China
4Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 355 West 16th Street, Suite 4100, Indianapolis, IN 46202, USA
5Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, 410 West 10th Street, Suite 5000, Indianapolis, IN 46202, USA
6Department of Biohealth Informatics, Indiana University School of Informatics and Computing, Indianapolis, IN 46202, USA

Received 15 December 2014; Accepted 17 March 2015

Academic Editor: Dongchun Liang

Copyright © 2015 Jin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Price and S. S. Sisodia, “Mutant genes in familial Alzheimer's disease and transgenic models,” Annual Review of Neuroscience, vol. 21, no. 1, pp. 479–505, 1998. View at Publisher · View at Google Scholar
  2. L. Bertram, C. M. Lill, and R. E. Tanzi, “The genetics of alzheimer disease: back to the future,” Neuron, vol. 68, no. 2, pp. 270–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Akiyama, K. Ikeda, H. Kondo, M. Kato, and P. L. McGeer, “Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease,” Neuroscience Letters, vol. 164, no. 1-2, pp. 233–235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Harold, R. Abraham, P. Hollingworth et al., “Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease,” Nature Genetics, vol. 41, pp. 1088–1093, 2009. View at Publisher · View at Google Scholar
  5. O. Belbin, M. M. Carrasquillo, M. Crump et al., “Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease,” Human Genetics, vol. 129, no. 3, pp. 273–282, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Carrasquillo, T. A. Hunter, L. Ma et al., “Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions,” Journal of Alzheimer's Disease, vol. 24, no. 4, pp. 751–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Hollingworth, D. Harold, R. Sims et al., “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease,” Nature Genetics, vol. 43, no. 5, pp. 429–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Naj, G. Jun, G. W. Beecham et al., “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease,” Nature Genetics, vol. 43, no. 5, pp. 436–441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Shi, O. Belbin, C. Medway et al., “Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS),” Neurobiology of Aging, vol. 33, no. 8, pp. e5–e18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-C. Lambert, C. A. Ibrahim-Verbaas, D. Harold et al., “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease,” Nature Genetics, vol. 45, no. 12, pp. 1452–1458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. F. Bence, R. M. Sampat, and R. R. Kopito, “Impairment of the ubiquitin-proteasome system by protein aggregation,” Science, vol. 292, no. 5521, pp. 1552–1555, 2001. View at Publisher · View at Google Scholar
  12. S. G. Potkin, J. A. Turner, G. Guffanti et al., “Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations,” Cognitive Neuropsychiatry, vol. 14, no. 4-5, pp. 391–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Dubois, H. H. Feldman, C. Jacova et al., “Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria,” The Lancet Neurology, vol. 6, no. 8, pp. 734–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson et al., “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease,” Brain, vol. 131, no. 6, pp. 1630–1645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Albert, S. T. DeKosky, D. Dickson et al., “The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease,” Alzheimer's and Dementia, vol. 7, no. 3, pp. 270–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Clark, J. A. Schneider, B. J. Bedell et al., “Use of florbetapir-PET for imaging beta-amyloid pathology,” The Journal of the American Medical Association, vol. 305, no. 3, pp. 275–283, 2011. View at Publisher · View at Google Scholar
  17. R. A. Sperling, P. S. Aisen, L. A. Beckett et al., “Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease,” Alzheimer's & Dementia, vol. 7, no. 3, pp. 280–292, 2011. View at Publisher · View at Google Scholar
  18. L. Shen, P. M. Thompson, S. G. Potkin et al., “Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 183–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Meda, M. E. I. Koran, J. R. Pryweller, J. N. Vega, and T. A. Thornton-Wells, “Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative,” Neurobiology of Aging, vol. 34, no. 5, pp. 1518.e9–1518.e18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Mateo, J. L. Vázquez-Higuera, P. Sánchez-Juan et al., “Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3β) and Alzheimer's disease risk,” Acta Neurologica Scandinavica, vol. 120, no. 2, pp. 130–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Rodríguez-Rodríguez, I. Mateo, J. Infante et al., “Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk,” Brain Research, vol. 1280, pp. 166–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Rodriguez-Rodriguez, J. L. Vázquez-Higuera, P. Sánchez-Juan et al., “Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk,” Journal of Alzheimer's Disease, vol. 21, no. 2, pp. 619–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. I. Koran, T. J. Hohman, and T. A. Thornton-Wells, “Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography,” Human Genetics, vol. 133, no. 1, pp. 85–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Thambisetty, Y. An, M. Nalls et al., “Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype,” Biological Psychiatry, vol. 73, no. 5, pp. 422–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Saykin, L. Shen, T. M. Foroud et al., “Alzheimer's disease neuroimaging initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans,” Alzheimer's & Dementia, vol. 6, no. 3, pp. 265–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Shen, S. Kim, S. L. Risacher et al., “Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort,” NeuroImage, vol. 53, no. 3, pp. 1051–1063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Purcell, B. Neale, K. Todd-Brown et al., “PLINK: a tool set for whole-genome association and population-based linkage analyses,” American Journal of Human Genetics, vol. 81, no. 3, pp. 559–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. L. Price, N. J. Patterson, R. M. Plenge, M. E. Weinblatt, N. A. Shadick, and D. Reich, “Principal components analysis corrects for stratification in genome-wide association studies,” Nature Genetics, vol. 38, no. 8, pp. 904–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. K. Pritchard, M. Stephens, and P. Donnelly, “Inference of population structure using multilocus genotype data,” Genetics, vol. 155, no. 2, pp. 945–959, 2000. View at Google Scholar · View at Scopus
  30. K.-L. Huang, K.-J. Lin, I.-T. Hsiao et al., “Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population,” PLoS ONE, vol. 8, no. 3, Article ID e58974, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. W. J. Jagust, S. M. Landau, L. M. Shaw et al., “Relationships between biomarkers in aging and dementia,” Neurology, vol. 73, no. 15, pp. 1193–1199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. M. Shaw, H. Vanderstichele, M. Knapik-Czajka et al., “Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects,” Annals of Neurology, vol. 65, no. 4, pp. 403–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Hampel, K. Blennow, L. M. Shaw, Y. C. Hoessler, H. Zetterberg, and J. Q. Trojanowski, “Total and phosphorylated tau protein as biological markers of Alzheimer's disease,” Experimental Gerontology, vol. 45, no. 1, pp. 30–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kim, S. Swaminathan, L. Shen et al., “Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort,” Neurology, vol. 76, no. 1, pp. 69–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Herold, M. Steffens, F. F. Brockschmidt, M. P. Baur, and T. Becker, “INTERSNP: genome-wide interaction analysis guided by a priori information,” Bioinformatics, vol. 25, no. 24, pp. 3275–3281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. V. K. Ramanan, S. L. Risacher, K. Nho et al., “APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study,” Molecular Psychiatry, vol. 19, no. 3, pp. 351–357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Guerreiro, J. Brás, A. Wojtas, R. Rademakers, J. Hardy, and N. Graff-Radford, “A nonsense mutation in PRNP associated with clinical Alzheimer's disease,” Neurobiology of Aging, vol. 35, no. 11, pp. 2656.e13–2656.e16, 2014. View at Publisher · View at Google Scholar
  39. C. Sassi, R. Guerreiro, R. Gibbs et al., “Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease,” Neurobiology of Aging, vol. 35, no. 12, pp. 2881.e1–2881.e6, 2014. View at Publisher · View at Google Scholar
  40. M. Ikonen, B. Liu, Y. Hashimoto et al., “Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 22, pp. 13042–13047, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Kochunov, J. Charlesworth, A. Winkler et al., “Transcriptomics of cortical gray matter thickness decline during normal aging,” NeuroImage, vol. 82, pp. 273–283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Potkin, G. Guffanti, A. Lakatos et al., “Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease,” PLoS ONE, vol. 4, no. 8, Article ID e6501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. W. Weiner, D. P. Veitch, P. S. Aisen et al., “The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception,” Alzheimer's and Dementia, vol. 9, no. 5, pp. e111–e194, 2013. View at Publisher · View at Google Scholar · View at Scopus